Great Bay Bio (GBB), a Hong Kong-based biotech firm, is looking to raise $20-30 million in a fresh funding round, its chairman and co-founder Kingsley Leung told DealStreetAsia.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
